CASQ2

Chr 1AR

calsequestrin 2

Also known as: PDIB2

Calsequestrin 2 is a high-capacity calcium-binding protein that stores calcium in the sarcoplasmic reticulum of cardiac muscle and regulates calcium release through the ryanodine receptor RYR2, playing a critical role in excitation-contraction coupling and heart rate regulation. Mutations cause catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2), characterized by stress-induced bidirectional ventricular tachycardia that can lead to cardiac arrest. CPVT2 follows autosomal recessive inheritance, and CASQ2 is highly intolerant to loss-of-function variants.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 1.381 OMIM phenotype
Clinical SummaryCASQ2
🧬
Gene-Disease Validity (ClinGen)
hypertrophic cardiomyopathy · ADDisputed

Disputed — evidence questions this relationship

3 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
69 unique Pathogenic / Likely Pathogenic· 219 VUS of 588 total submissions
📖
GeneReview available — CASQ2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.38LOEUF
pLI 0.000
Z-score 0.26
OE 0.94 (0.651.38)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.20Z-score
OE missense 1.04 (0.931.16)
217 obs / 209.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.94 (0.651.38)
00.351.4
Missense OE1.04 (0.931.16)
00.61.4
Synonymous OE1.07
01.21.6
LoF obs/exp: 19 / 20.3Missense obs/exp: 217 / 209.1Syn Z: -0.47
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedCASQ2-related hypertrophic cardiomyopathyOTHERAD
definitiveCASQ2-related catecholaminergic polymorphic ventricular tachycardiaLOFAR
moderateCASQ2-related catecholaminergic polymorphic ventricular tachycardiaOTHERAD
DN
0.6647th %ile
GOF
0.4874th %ile
LOF
0.2970th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

588 submitted variants in ClinVar

Classification Summary

Pathogenic33
Likely Pathogenic36
VUS219
Likely Benign249
Benign15
Conflicting33
33
Pathogenic
36
Likely Pathogenic
219
VUS
249
Likely Benign
15
Benign
33
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
22
3
8
0
33
Likely Pathogenic
30
5
1
0
36
VUS
2
182
34
1
219
Likely Benign
2
5
131
111
249
Benign
0
1
14
0
15
Conflicting
33
Total56196188112585

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CASQ2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →